cyanopindolol has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammer, H; Schulz, R | 1 |
| Esbenshade, TA; Granneman, JG; Han, C; Minneman, KP; Theroux, TL | 1 |
2 other study(ies) available for cyanopindolol and Neuroblastoma
| Article | Year |
|---|---|
Opioid tolerance/dependence in neuroblastoma x glioma (NG108-15) hybrid cells is associated with a reduction in spontaneous stimulatory receptor activity.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Binding, Competitive; COS Cells; Drug Tolerance; Enzyme Inhibitors; Glioma; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hybrid Cells; Iodine Radioisotopes; Morphine; Narcotics; Neuroblastoma; Pindolol; Propanolamines; Receptors, Adrenergic, beta-2; Signal Transduction; Transfection | 2000 |
Coexisting beta 1- and atypical beta-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cyclic AMP; Ethanolamines; Humans; Imidazoles; Isoproterenol; Neuroblastoma; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; RNA, Messenger; Tumor Cells, Cultured | 1992 |